Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check4 days agoChange DetectedNo additions or deletions were described for this page in the provided input.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 on the page; no study data, results, or functionality are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision bumped from v3.4.0 to v3.4.1 with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI and metadata changes include adding a Show glossary option and updating QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' (with minor wording changes for No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedMinor UI adjustments and a refreshed last updated timestamp on the Study Details page; core study information remains unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision entry added: v3.3.4; revision entry removed: v3.3.3 from the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.